GlassScriptPhysician profile
James Mcquade
NPI 1942841077
$2,354.37
in general payments reported to CMS, 2019-2025
14 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $529 · 2022: $375 · 2023: $703 · 2024: $427 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,450.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $365.06 | 2021-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $343.82 | 2021-2025 | Lifevest |
| Csl Behring | $322.72 | 2023-2025 | Kcentra, Haegarda |
| Abbvie INC. | $291.38 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $291.35 | 2021-2024 | Xarelto |
| Pfizer INC. | $201.46 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $115.32 | 2021-2023 | |
| Baxter Healthcare | $100.00 | 2021 | |
| Daiichi Sankyo INC. | $75.84 | 2023-2024 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.44 | 2022-2023 | Jardiance |
| Atricure, INC. | $62.16 | 2024 | |
| Merck Sharp & Dohme LLC | $45.62 | 2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $38.80 | 2024 | Farxiga |
| Kestra Medical Technology Services, INC. | $25.40 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcquade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.